CRYPTOCOCCAL ANTIGENAEMIA IN ANTIRETROVIRAL THERAPY NAIVE PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION.

Simoes EA, Babu GP, John TJ, et al. Evidence for HTLV-3 infection in prostitutes in Tamil Nadu (India). Indian J Med Res 1987;85:335-8.                 

Sharma SK, Kadhiravan T, Banga A, et al. Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients of north India. BMC Infected Dis 2004;4:52.                                          

Lakshmi V, Sudha T, Teja VD, et al. Prevalence of central nervous system cryptococcosis in human immunodeficiency virus reactive hospitalized patients. Indian Med Microbiol 2007;25(2):146-9.                 

Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23(4):525-30.                     

Churchyard GJ, Kleinschmidt I, Corbett EL, et al. Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis 2000;4(8):705-12.             

Manoharan G, Padmavathy BK, Vasanthi S, et al. Cryptococcal meningitis among HIV-infected patients. Indian J Med Microbiol 2001;19(3):157-8.        

Rao VK, Thomas FP. Neurological complications of HIV/AIDS. BETA 2005;17(2):37-46.                           

French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002;16(7):1031-8.                     

Liechty CA, Solberg P, Were W, et al. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health 2007;12(8):929-35.                        

Kambugu A, Meya DB, Rhein J, et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008;46(11):1694-701.            

Tenna A. Screening for cryptococcal infection in HIV-infected patients visiting HIV clinics at two hospitals in Addis Ababa, Ethiopia. 3rd Methods in International Neuro AIDS Rearch 2011.               

Tassie JM, Pepper L, Fogg C, et al. Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda. J Acquir Immune Defic Syndr 2003;33(3):411-2.                       

Oyella J, Meya D, Bajunirwe F, et al. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross sectional study. J Int AIDS Soc 2012;15(1):15.              

Gomerep SS, Idoko JA, Ladep NG, et al. Frequency of cryptococcal meningitis in HIV–1 infected patients in north central Nigeria. Niger J Med 2010;19(4):395-9.   

Osazuwa F, Dirisu JO, Okuonghae PE, et al. Screening for cryptococcal antigenenemia in anti-retroviral naïve AIDS patient in benin city, Nigeria. Oman Med J 2012;27(3):228-31.    

Beyene T, Woldeamanuel Y, Asrat D, et al. Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia. PLoS One 2013;8(10):e75585.             

Micol R, Lortholary O, Sar B, et al. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr 2007;45(5):555-9.               

Andama AO, den Boon S, Meya D, et al. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda. J Acquir Immune Defic Syndr 2013;63(2):189-94.